The British biopharm company ScanCell, which specializes in cancer immunotherapy, has developed a vaccine against the coronavirus that has not yet been tested in humans. According to the authors, it will potentially provide protection against various mutations in the SARS-CoV-2 spike protein, such as “British”, “South African” and “Brazilian”. Writes about this The Telegraph. […]